Effects of intracerebroventricular infusion of angiotensin-(1-7) on bradykinin formation and the kinin receptor expression after focal cerebral ischemia-reperfusion in rats

Brain Research

Volumn 1219, Issue , 2008, Pages 127-135

  Lu, Jie ^a   Zhang, Yingdong ^a   Shi, Jingping ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); Bradykinin; Cerebral ischemia reperfusion; Kinin receptor; Renin angiotensin system

Indexed keywords

ANGIOTENSIN[1-7]; BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; LOW DRUG DOSE; MALE; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OSMOTIC MINIPUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANGIOTENSIN I; ANIMALS; BRADYKININ; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; REPERFUSION; RNA, MESSENGER;

ANIMALIA; RATTUS;

EID: 45849126088     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.057     Document Type: Article

References (49)

1. Abbas A., Gorelik G., Carbini L.A., and Scicli A.G. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension 30 (1997) 217-221
2. Ashwal S., Tone B., Tian H.R., Cole D.J., and Pearce W.J. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29 (1998) 1037-1046
3. Becker L.K., Etelvino G.M., Walther T., Santos R.A., and Campagnole-Santos M.J. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am. J. Physiol, Heart Circ. Physiol. 293 (2007) 1481-1512
4. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins-kallikreins, kininogens and kininases. Pharmacol. Rev. 44 (1992) 1-80
5. Brosnihan K.B., Li P., and Ferrario C.M. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27 (1996) 523-528
6. Carvalho M.B., Duarte F.V., Faria-Silva R., Fauler B., da Mata Machado L.T., de Paula R.D., Campagnole-Santos M.J., and Santos R.A. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats. Hypertension 50 (2007) 762-767
7. 1 receptor expression in aorta of rats. Hypertension 50 (2007) 756-761
8. Chalela J.A., Merino J.G., and Warach S. Update on stroke. Curr. Opin. Neurol. 17 (2004) 447-451
9. Chao J., and Chao L. Experimental therapy with tissue kallikrein against cerebral ischemia. Front. Biosci. 11 (2006) 1323-1327
10. Ferrario C.M., Chappell M.C., Tallant E.A., Brosnihan K.B., and Diz D.I. Counterregulatory actions of angiotensin-(1-7). Hypertension 30 (1997) 535-541
11. Ferreira A.J., and Santos R.A. Cardiovascular actions of angiotensin-(1-7). Braz. J. Med. Biol. Res. 38 (2005) 499-507
12. Ferreira A.J., Santos R.A., and Almeida A.P. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38 (2001) 665-668
13. Francel P.C. Bradykinin and neuronal injury. J. Neurotrauma 9 (1992) S27-S45
14. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., Speth R.C., Raizada M.K., and Katovich M.J. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). AmJ. Physiol, Heart Circ. Physiol. 292 (2007) H736-H742
15. Hashimoto N., Takeyoshi I., Tsutsumi H., Sunose Y., Tokumine M., Totsuka O., Ohwada S., Matsumoto K., and Morishita Y. Effects of a bradykinin B(2) receptor antagonist on ischemia-reperfusion injury in a canine lung transplantation model. J. Heart Lung Transplant. 23 (2004) 606-613
16. Hecker M., Blaukat A., Bara A.T., Müller-Esterl W., and Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br. J. Pharmacol. 121 (1997) 1475-1481
17. Hellner K., Walther T., Schubert M., and Albrecht D. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol. Cell. Neurosci. 29 (2005) 427-435
18. Kintsurashvili E., Duka I., Gavras I., Johns C., Farmakiotis D., and Gavras H. Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am. J. Physiol, Heart Circ. Physiol. 281 (2001) H1778-H1783
19. 2 receptor inhibition after focal cerebral ischemia in rats. Neurochem. Int. 49 (2006) 442-447
20. Kucharewicz I., Pawlak R., Matys T., Chabielska E., and Buczko W. Angiotensin-(1-7): an active member of the renin-angiotensin system. J. Physiol. Pharmacol. 53 (2002) 533-540
21. Iwadate H., Kawamata K., Kudo M., and Kizuki K. Biochemical and immunohistochemical demonstration of tissue kallikrein in the neuronal nuclei of the developing rat brains. Brain Res. 863 (2000) 87-93
22. Lee J.M., Zipfel G.J., and Choi D.W. The changing landscape of ischemic brain injury mechanisms. Nature 399 (1999) A7-A14
23. Lima C.V., Paula R.D., Resende F.L., Khosla M.C., and Santos R.A. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 30 (1997) 542-548
24. Longa E.Z., Weinstein P.R., Carlson S., and Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20 (1989) 84-91
25. Loot A.E., Roks A.J., Henning R.H., Tio R.A., Suurmeijer A.J., Boomsma F., and van Gilst W.H. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105 (2002) 1548-1550
26. Mahon J.M., Carr R.D., Nicol A.K., and Henderson I.W. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin II receptor. J. Hypertens. 12 (1994) 1377-1381
27. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., Ifuku M., Kosai Y., Wang B., Nolte C., Aoki S., Kettenmann H., and Wada K. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J. Neurochem. 101 (2007) 397-410
28. Paula R.D., Lima C.V., Khosla M.C., and Santos R.A. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 26 (1995) 1154-1159
29. Pereira R.M., Dos Santos R.A., Teixeira M.M., Leite V.H., Costa L.P., da Costa Dias F.L., Barcelos L.S., Collares G.B., and Simões e Silva A.C. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J. Hepatol. 46 (2007) 674-681
30. Polizio A.H., Gironacci M.M., Tomaro M.L., and Peña C. Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production. Pharmacol. Res. 56 (2007) 86-90
31. Raidoo D.M., Ramsaroop R., Naidoo S., and Bhoola K.D. Regional distribution of tissue kallikrein in the human brain. Immunopharmacology 32 (1996) 39-47
32. Rastelli V.M., Oliveira M.A., dos Santos R., de Cássia Tostes Passaglia R., Nigro D., de Carvalho M.H., and Fortes Z.B. Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin. Peptides 28 (2007) 1040-1049
33. Roks A.J., van Geel P.P., Pinto Y.M., Buikema H., Henning R.H., de Zeeuw D., and van Gilst W.H. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 34 (1999) 296-301
34. Rowe B.P., Saylor D.L., Speth R.C., and Absher D.R. Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain. Regul. Pept. 56 (1995) 139-146
35. Sampaio W.O., Henrique de Castro C., Santos R.A., Schiffrin E.L., and Touyz R.M. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50 (2007) 1093-1098
36. Santos R.A., and Ferreira A.J. Angiotensin-(1-7) and the renin-angiotensin system. Curr. Opin. Nephrol. Hypertens. 16 (2007) 122-128
37. Santos R.A., Campagnole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul. Pept. 91 (2000) 45-62
38. Schmaier A.H. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R1-R13
39. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 14 333 (1995) 1581-1587
40. Tom B., de Vries R., Saxena P.R., and Danser A.H. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade. Hypertension 38 (2001) 95-99
41. Tom B., Dendorfer A., and Danser A.H. Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?. Int. J. Biochem. Cell Biol. 35 (2003) 792-801
42. 2 receptor antagonist in extended liver resection with ischemia in dogs. Hepatogastroenterology 51 (2004) 1771-1775
43. Trask A.J., and Ferrario C.M. Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments. Cardiovasc. Drug Rev. 25 (2007) 162-174
44. 1 blockade after experimental myocardial infarction. Cardiovasc. Res. 61 (2004) 559-569
45. von Bohlen O., and Albrecht D. The CNS renin-angiotensin system. Cell Tissue Res. 326 (2006) 599-616
46. 2 receptors in the immune response triggered by renal ischemia-reperfusion injury. Int. Immunopharmacol. 6 (2006) 1960-1965
47. Xia C.F., Yin H., Borlongan C.V., Chao L., and Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension 43 (2004) 452-459
48. 2 receptor. Hypertension 47 (2006) 752-761
49. Zausinger S., Hungerhuber E., Baethmann A., Reulen H., and Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res. 863 (2000) 94-105